The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants

Cytokine

Volumn 58, Issue 1, 2012, Pages 57-64

  Kapitanović Vidak, Helena ^a   Catela Ivković, Tina ^b   Jokić, Mladen ^b   Spaventi, Radan ^c   Kapitanović, Sanja ^b  

^a Special Hospital for Children with Neurodevelopmental and Motor Difficulties   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c Galapagos Research Center doo   (Croatia)

Author keywords

Cerebral palsy; Cytokine gene polymorphisms; IL1 ; TNF ; Very premature infants

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BLEEDING; BRAIN INFARCTION; CEREBRAL PALSY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; HUMAN; INFANT; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE; ULTRASOUND; VERY PRETERM INFANT;

CEREBRAL PALSY; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; POLYMORPHISM, GENETIC; PREGNANCY; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857450287     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.12.018     Document Type: Article

References (58)

1. Bax M., Goldstein M., Rosenbaum P., Leviton A., Paneth N., Dan B., et al. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 2005, 47:571-576.
2. Hagberg B., Hagberg G., Beckung E., Uvebrant P. Changing panorama of cerebral palsy in Sweden VIII Prevalence and origin in the birth year period 1991-94. Acta Paediatr 2001, 90:271-277.
3. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathol 2005, 15:234-240.
4. Sado T., Kitanaka T., Naruse K., Oi H., Noguchi T., Yoshida S., et al. Anticytokine therapy in preterm labor. Current knowledge and future perspectives. Gynecol Obstet Invest 2010, 71:1-10.
5. Haas DM. Preterm birth. Clin Evid (Online); 2011. p. 1404.
6. Arpino C., D'Argenzio L., Ticconi C., Di Paolo A., Stellin V., Lopez L., et al. Brain damage in preterm infants: etiological pathways. Ann Ist Super Sanita 2005, 41:229-237.
7. Volpe J.J. Neurobiology of periventricular leucomalacia in the premature infant. Pediatr Res 2001, 50:553-562.
8. Rezaie P., Dean A. Periventricular leucomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002, 22:106-132.
9. Holst D., Garnier Y. Preterm birth and inflammation - the role of genetic polymorphisms. Eur J Obstet Gynecol Reprod Biol 2008, 141:3-9.
10. Bashiri A., Burstein E., Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med 2006, 34:5-12.
11. Back S.A., Riddle A., McClure M.M. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 2007, 38:724-730.
12. Duggan P.J., Maalouf E.F., Watts T.L., Sullivan M.H., Counsell S.J., Allsop J. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001, 358:1699-1700.
13. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998, 79:194-202.
14. Yoon B.H., Romero R., Yang S.H., Jun J.K., Kim I.O., Choi J.H. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174:1433-1440.
15. Yoon B.H., Jun J.K., Romero R., Park K.H., Gomez R., Choi J.H., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1b and tumor necrosis factor-α) neonatal brain white matter lesions and cerebral palsy. Am J Obstet Gynecol 1997, 177:19-26.
16. Baud O., Emilie D., Pelletier E., Lacaze-Masmonteil T., Zupan V., Fernandez H., et al. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol 1999, 106:72-77.
17. Kadhim H., Tabarki B., Verellen G., De Prez C., Rona A.M., Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
18. Haukim N., Bidwell J.L., Smith A.J., Keen L.J., Gallagher G., Kimberly R. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002, 3:313-330.
19. Cigrovski Berković M., Jokić M., Marout J., RadoŠević S., Zjačić-Rotkvić V., Kapitanović S. IL-6 -174 C/G polymorphism in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Exp Mol Pathol 2007, 83:474-479.
20. Speer E.M., Gentile D.A., Zeevi A., Pillage G., Huo D., Skoner D.P. Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Hum Immunol 2006, 67:915-923.
21. Baier R.J. Genetics of perinatal brain injury in the preterm infants. Front Biosci 2006, 11:1371-1387.
22. Deng W. Neurobiology of the injury to the developing brain. Nat Rev Neurol 2010, 6:328-336.
23. Volpe J.J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124.
24. Pleasure D., Soulika A., Singh S.K., Gallo V., Bannerman P. Inflammation in white matter: clinical and pathophysiological aspects. Ment Retard Dev Disabil Res Rev 2006, 12:141-146.
25. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001, 21:1302-1312.
26. Back S.A., Luo N.L., Borenstein N.S., Volpe J.J., Kinney H.C. Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 2002, 61:197-211.
27. Larroque B., Bréart G., Kaminski M., Dehan M., André M., Burguet A., et al. Survival of very preterm infants: EPIPAGE, a population based study. Arch Dis Child Fetal Neonatal Ed 2004, 89:F139-F144.
28. Johnston M.V., Hagberg H. Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 2005, 47:571-576.
29. Kuban K.C., Leviton A. Cerebral palsy. N Engl J Med 1994, 330:188-195.
30. Folkerth R.D. Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol 2006, 9:3-13.
31. De Vries L.S., Van Haastert I.L., Rademaker K.J., Koopman C., Groenendaal F. Ultrasound abnormalities preceding cerebral palsy in high-risk preterm infants. J Pediatris 2004, 144:815-820.
32. Ancel P.Y., Livinec F., Larroque B., Marret S., Arnaud C., Pierrat V., et al. EPIPAGE Study Group. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrics 2006, 117:828-835.
33. Paneth N., Rudelli R., Kazam E., Monte W. Brain damage in the preterm infant clinics in developmental medicine No. 131 1994, Mac Keith Press, London.
34. Leviton A., Gilles F. Ventriculomegaly, delayed myelination, white matter hypoplasia, and 'periventricular' leucomalacia: how are they related?. Pediatr Neurol 1996, 15:127-136.
35. Holling E.E., Leviton A. Characteristics of cranial ultrasound white matter echolucencies that predict disability: a review. Dev Med Child Neurol 1999, 41:136-139.
36. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link?. Dev Med Child Neurol 1993, 35:553-558.
37. Nelson K.B., Willoughby R.E. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000, 13:133-139.
38. Nelson K.B., Dambrosia J.M., Grether J.K., Phillips T.M. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998, 44:665-675.
39. Baud O., Foix-L'Helias L., Kaminski M., Audibert F., Jarreau P.H., Papiernik E., et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999, 341:1190-1196.
40. Huleihel M., Golan H., Hallak M. Intrauterine infection/inflammation during pregnancy and offspring brain damages: possible mechanisms involved. Reprod Biol Endocrinol 2004, 2:17.
41. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992, 14:1-10.
42. Mehler M.F., Kessler J.A. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 1997, 20:357-365.
43. Toulmond S., Parnet P., Linthorst A.C. When cytokines get on your nerves: cytokine network and CNS pathologes. Trends Neurosci 1996, 19:409-410.
44. Sherwin C., Fern R. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-α, IL-1β and calcium. J Immunol 2005, 175:155-161.
45. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., et al. Cytokine gene polymorphism in human disease: on line databases. Genes Immun 1999, 1:3-19.
46. Tsukasaki K., Miller C.W., Kubota T., Takeuchi S., Fujimoto T., Ikeda S., et al. Tumor necrosis factor a polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001, 61:3770-3774.
47. Gibson C.S., MacLennan A.H., Goldwater P.N., Haan E.A., Priest K., Dekker G.A. For the South Australian Cerebral Palsy Research Group. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006, 194:674.e1-674.e11.
48. Nelson K.B., Dambrosia J.M., Iovannisci D.M., Cheng S., Grether J.K., Lammer E. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 2005, 57:494-499.
49. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
50. Stuber F., Udalova I.A., Book M., Drutskaya L.N., Kuprash D.V., Turetskaya R.L., et al. 308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995, 46:42-50.
51. Bayley J.P., Ottenhoff T.H., Verweij C.L. Is there a future for TNF promoter polymorphisms. Genes Immun 2004, 5:315-329.
52. Pociot F., Mølvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992, 22:396-402.
53. Chen H., Wilkins L.M., Aziz N., Cannings C., Wyllie D.H., Bingle C., et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006, 15:519-529.
54. Naka T., Nishimoto N., Kishimoto T. The paradigm of IL6: from basic science to medicine. Arthritis Res 2002, 4:S233-S242.
55. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin 6 (IL6) gene on IL6 transcription and plasma IL6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
56. Chauhan M., McGuire W. Interleukin-6 (-174) polymorphism and the risk of sepsis in very-low-birth-weight infants: meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008, 93:F427-F429.
57. Harding D.R., Dhamrait S., Whitelaw A., Humphries S.E., Marlow N., Montgomery H.E. Does interleukin 6 genotype influence cerebral injury or developmental progress after preterm birth?. Pediatrics 2004, 114:941-947.
58. Göpel W., Härtel C., Ahrens P., König I., Kattner E., Kuhls E., et al. Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants. Genes Immun 2006, 7:65-68.